MedTrace Logo

Minocycline Treatment in Acute Hemorrhagic Stroke

NCT01388127 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2011-07-06

No results posted yet for this study

Summary

The investigators will perform a double blind controlled study to investigate the efficacy of oral administration of 200 mg minocycline, on the neurological and functional outcome after acute hemorrhagic stroke and the effect on blood brain barrier permeability.

Conditions

  • Poor Performance Status

Sponsors & Collaborators

  • Wolfson Medical Center

    lead OTHER_GOV

Principal Investigators

  • Yair Lampl, MD · Edith Wolfson Medical Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01388127 on ClinicalTrials.gov